Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection

NCT06309628 is registered in ClinicalTrials.gov with Paragonix Technologies as lead sponsor.

NCT NCT06309628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06309628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection
Lead sponsor
Paragonix Technologies
Phase
Observational
Overall status
Terminated
Start date
September 21, 2023
Completion date
May 9, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant rejection